ABCG8 gene polymorphisms, plasma cholesterol concentrations, and risk of cardiovascular disease in familial hypercholesterolemia

被引:39
|
作者
Koeijvoets, Kristel C. M. C. [1 ]
van der Net, Jeroen B. [1 ,2 ]
Dallinga-Thie, Geesje M. [3 ]
Steyerberg, Ewout W. [2 ]
Mensink, Ronald P. [4 ]
Kastelein, John J. P. [3 ]
Sijbrands, Eric J. G. [1 ]
Plat, Jogchum [4 ]
机构
[1] Erasmus MC, Dept Internal Med, NL-3000 AC Rotterdam, Netherlands
[2] Erasmus MC, Dept Publ Hlth, NL-3000 AC Rotterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
[4] Maastricht Univ, Dept Human Biol, Maastricht, Netherlands
关键词
ABCG8; Polymorphism; Cardiovascular disease; Familial hypercholesterolemia; Plant sterols; CORONARY-HEART-DISEASE; SERUM PLANT STEROLS; NONCHOLESTEROL STEROLS; DIETARY-CHOLESTEROL; ARTERY-DISEASE; SITOSTEROLEMIA; ACCUMULATION; TRANSPORTERS; ASSOCIATION; METABOLISM;
D O I
10.1016/j.atherosclerosis.2008.09.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Elevated plasma plant sterol concentrations may be a risk factor of cardiovascular disease (CVD). Polymorphisms in the ABCG8 gene have been identified that contribute to the variation in plasma concentrations of plant sterols. However, data on the direct relationship of ABCG8 gene polymorphisms with CVD are lacking. Therefore, we examined associations between the D19H and T400K polymorphisms in the ABCG8 gene and CVD in a large cohort study of 2012 patients with heterozygous familial hypercholesterolemia (FH). A total of 244 individuals carried one or two alleles of the D19H variant and 568 individuals the T400K variant. During 94,809 person years, 648 (32.2%) individuals developed CVD of which coronary heart disease (CHD) was the most frequent cardiovascular event (N=553). In a Cox proportional hazard regression model adjusted for relevant cardiovascular risk factors, the D19H polymorphism was not associated with total CVD risk (p = 0.2), but there was evidence of an association with higher risk of CHD (RR 1.42, CI 1.04-1.95; p = 0.03). We observed no relationship between the T400K polymorphism and cardiovascular endpoints (p > 0.1). However, FH individuals carrying the risk genotype for both ABCG8 variants had an increased risk of CVD (RR 1.57, 95% CI 1.13-2.18; p = 0.01) and CHD (RR 1.72, 95% Cl 1.23-2.41; p = 0.002). In conclusion, our data suggest that genetic variation in the ABCG8 gene may influence the burden of atherosclerosis. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:453 / 458
页数:6
相关论文
共 50 条
  • [41] Usefulness of Genetic Polymorphisms and Conventional Risk Factors to Predict Coronary Heart Disease in Patients With Familial Hypercholesterolemia
    van der Net, Jeroen B.
    Janssens, A. Cecile J. W.
    Defesche, Joep C.
    Kastelein, John J. P.
    Sijbrands, Eric J. G.
    Steyerberg, Ewout W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (03) : 375 - 380
  • [42] Replication study of 10 genetic polymorphisms associated with coronary heart disease in a specific high-risk population with familial hypercholesterolemia
    van der Net, Jeroen B.
    Oosterveer, Daniella M.
    Versmissen, Jorie
    Defesche, Joep C.
    Yazdanpanah, Mojgan
    Aouizerat, Bradley E.
    Steyerberg, Ewout W.
    Malloy, Mary J.
    Pullinger, Clive R.
    Kastelein, John J. P.
    Kane, John P.
    Sijbrands, Eric J. G.
    EUROPEAN HEART JOURNAL, 2008, 29 (18) : 2195 - 2201
  • [43] Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)
    Boutari, Chrysoula
    Rizos, Christos V. V.
    Doumas, Michalis
    Liamis, George
    Skoumas, Ioannis
    Rallidis, Loukianos
    Garoufi, Anastasia
    Kolovou, Genovefa
    Tziomalos, Konstantinos
    Skalidis, Emmanouil
    Kotsis, Vasileios
    Sfikas, George
    Lambadiari, Vaia
    Anagnostis, Panagiotis
    Bilianou, Eleni
    Anastasiou, Georgia
    Koutagiar, Iosif
    Kiouri, Estela
    Attilakos, Achilleas
    Kolovou, Vana
    Zacharis, Evangelos
    Antza, Christina
    Liberopoulos, Evangelos
    PHARMACEUTICALS, 2023, 16 (01)
  • [44] PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients
    Leus, FR
    Zwart, M
    Kastelein, JJP
    Voorbij, HAM
    ATHEROSCLEROSIS, 2001, 154 (03) : 641 - 649
  • [45] Perceived Risk and Representations of Cardiovascular Disease and Preventive Behaviour in People Diagnosed with Familial Hypercholesterolemia A Cross-sectional Questionnaire Study
    Claassen, Liesbeth
    Henneman, Lidewij
    Kindt, Iris
    Marteau, Theresa M.
    Timmermans, Danielle R. M.
    JOURNAL OF HEALTH PSYCHOLOGY, 2010, 15 (01) : 33 - 43
  • [46] A Double Mutant [N543H+2393del9] Allele in the LDL Receptor Gene in Familial Hypercholesterolemia: Effect on Plasma Cholesterol Levels and Cardiovascular Disease
    Castillo, S.
    Reyes, G.
    Tejedor, D.
    Mozas, P.
    Suarez, Y.
    Lasuncion, M. A.
    Cenarro, A.
    Civeira, F.
    Alonso, R.
    Mata, P.
    Pocovi, M.
    HUMAN MUTATION, 2002, 20 (06) : 477
  • [47] Annexin A5 haplotypes in familial hypercholesterolemia: Lack of association with carotid intima-media thickness and cardiovascular disease risk
    Hiddink, Larissa
    Dallinga-Thie, Geesje M.
    Hovingh, G. Kees
    de Visser, Marieke C. H.
    Peer, Petronella G. M.
    Stalenhoef, Anton F. H.
    van Heerde, Waander L.
    ATHEROSCLEROSIS, 2015, 238 (02) : 195 - 200
  • [48] Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia
    Trinder, Mark
    Paquette, Martine
    Cermakova, Lubomira
    Ban, Matthew R.
    Hegele, Robert A.
    Baass, Alexis
    Brunham, Liam R.
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2020, 13 (05): : 515 - 523
  • [49] Serum homocysteine, methylenetetrahydrofolate reductase gene polymorphism and cardiovascular disease in heterozygous familial hypercholesterolemia
    Pisciotta, L
    Cortese, C
    Gnasso, A
    Liberatoscioli, L
    Pastore, A
    Mannucci, L
    Irace, C
    Federici, G
    Bertolini, S
    ATHEROSCLEROSIS, 2005, 179 (02) : 333 - 338
  • [50] Association of estrogen receptor-α gene polymorphisms with coronary artery disease in patients with familial hypercholesterolemia
    Lu, H
    Higashikata, T
    Inazu, A
    Nohara, A
    Yu, WX
    Shimizu, M
    Mabuchi, H
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) : 817 - 823